Additional information
| Active substance | Human Growth Hormone |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Hormone levels (LH, FSH) |
| Also known as | GnRH agonist implant |
| WAREHOUSE | International Warehouse 3 |
| Blood pressure | No significant effects |
| Trade name | Suprelorin, Ovuplant |
| Storage conditions | Store at controlled room temperature, protect from light |
| Chemical name | Deslorelin acetate |
| Formula | C64H83N17O12В·C2H4O2 |
| Substance class | Gonadotropin-releasing hormone agonist (GnRH agonist) |
| Main action | Increases the production of gonadotropins |
| Half-life | 2-3 hours |
| Dosage (medical) | Typically, 2.1 mg implant every 6 months |
| Dosage (sports) | Not applicable |
| Effects | Induces a temporary decrease in gonadotropin secretion |
| Side effects | Local injection site reactions, altered testosterone levels, potential bone density reduction |
| Use in sports | Not typically used or recommended in sports |
| Manufacturer | Beligas |
Fostimon (Merional) 75 (HMG) IBSA
FACTIVE 320 mg Abdi Ibragim
AVELOX 400 Bayer
Zyban Glaxosmithkline
Spiriva HandiHaler 18mg Boehringer Ingelheim
Zimaks 400 Bilim
Fostimon (Merional) 150 IU HMG IBSA
Januvia 100mg Merckgroup
LACIPIL 4 mg Glaxosmithkline
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Norvacs 10 mg Pfizer
Champix 56 tabs Pfizer 

Reviews
There are no reviews yet.